Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mahmoud Moustafa Hamada"'
Autor:
Mohamed Abdel‐Salam Elgohary, Mohamed Emam Mohamed, Mahmoud Moustafa Hamada, Jackline S. Fahim, Thanaa A. El‐Masry, Ahmed Mohamed Ibrahim, Ahmad Gad Taha, Mohamed G. Seadawy, Athanasios Alexiou, Marios Papadakis, Gaber El‐Saber Batiha, Maisra M. El‐Bouseary
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message Our case report demonstrates extremely uncommon data associated with MIS‐A, such as cholestatic jaundice, anemia, and quickly progressing pneumonia. IVIG and pulse steroid medications are the best treatments for improving clini
Externí odkaz:
https://doaj.org/article/3cd20ef8b5214e98b54f6bed102b1d9f
Autor:
Mohamed Abdel-Salam, Elgohary, Eman Medhat, Hasan, Amany Ahmad, Ibrahim, Mohamed Farouk Ahmed, Abdelsalam, Raafat Zaher, Abdel-Rahman, Ashraf Ibrahim, Zaki, Mohamed Bakr, Elaatar, Mohamed Thabet, Elnagar, Mohamed Emam, Emam, Mahmoud Moustafa, Hamada, Taimour Mohamed, Abdel-Hamid, Ahmad Samir, Abdel-Hafez, Mohamed Gomaa, Seadawy, Ahmad Rashad, Fatoh, Mohamed Ali, Elsaied, Marwa Abdel-Rahman, Sakr, Ahmed Omar, Elkady, Mohamed Muawad, Shehata, Osama Mohamed, Nawar, Mohamed Abu-Elnaga, Selem, Mohamed Saeed, Abd-Aal, Hany Hafez, Lotfy, Tarek Refaat, Elnagdy, Sherine, Helmy, Magdy Amin, Mubark
Publikováno v:
Journal of Medicine and Life. 15:350-358
COVID-19 is a pandemic disease caused by SARS-CoV-2, which is an RNA virus similar to the hepatitis C virus (HCV) in the replication process. Sofosbuvir/ledipasvir is an approved drug to treat HCV infection. This study investigates the efficacy of So
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0736e3210add4099fea0de01b52f443
https://doi.org/10.25122/jml-2021-0175
https://doi.org/10.25122/jml-2021-0175
Autor:
Ahmad Samir Abdel-Hafez, Mohamed Abu-elnaga Selem, Hany Hafez Lotfy, Mohamed Ali Elsaied, Ashraf Ibrahim Zaki, Osama Mohamed Nawar, Amany M.A. Ibrahim, Marwa Abdel-Rahman Sakr, Mohamed Emam Emam, Ahmed Omar Elkady, Ahmad Rashad Fatoh, Magdy Amin Mubark, Eman M. Hasan, Mohamed Abdel-Salam Elgohary, Mohamed Farouk Ahmed, Mohamed Saeed Abd-aal, Mahmoud Moustafa Hamada, Mohamed Muawad Shehata, Mohamed Thabet Elnagar, Taimour Mohamed Abdel-Hamid, Raafat Zaher Abdel-Rahman, Mohamed G. Seadawy, Mohamed Bakr Elaatar, Sherine Helmy, Tarek Refaat Elnagdy
BackgroundCOVID-19 is a pandemic disease caused by SARS-CoV-2, which is an RNA virus similar to HCV in the replication process. Sofosbuvir/ledipasvir is an approved drug by the FDA to treat HCV infection. This study investigates the efficacy of Sofos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d056f640a712d22158ead0a8c8df5c43
https://doi.org/10.1101/2021.05.19.21257429
https://doi.org/10.1101/2021.05.19.21257429
